Skip to Content
Merck
  • Molecular basis for fibroblast growth factor 23 O-glycosylation by GalNAc-T3.

Molecular basis for fibroblast growth factor 23 O-glycosylation by GalNAc-T3.

Nature chemical biology (2020-01-15)
Matilde de Las Rivas, Earnest James Paul Daniel, Yoshiki Narimatsu, Ismael Compañón, Kentaro Kato, Pablo Hermosilla, Aurélien Thureau, Laura Ceballos-Laita, Helena Coelho, Pau Bernadó, Filipa Marcelo, Lars Hansen, Ryota Maeda, Anabel Lostao, Francisco Corzana, Henrik Clausen, Thomas A Gerken, Ramon Hurtado-Guerrero
ABSTRACT

Polypeptide GalNAc-transferase T3 (GalNAc-T3) regulates fibroblast growth factor 23 (FGF23) by O-glycosylating Thr178 in a furin proprotein processing motif RHT178R↓S. FGF23 regulates phosphate homeostasis and deficiency in GALNT3 or FGF23 results in hyperphosphatemia and familial tumoral calcinosis. We explored the molecular mechanism for GalNAc-T3 glycosylation of FGF23 using engineered cell models and biophysical studies including kinetics, molecular dynamics and X-ray crystallography of GalNAc-T3 complexed to glycopeptide substrates. GalNAc-T3 uses a lectin domain mediated mechanism to glycosylate Thr178 requiring previous glycosylation at Thr171. Notably, Thr178 is a poor substrate site with limiting glycosylation due to substrate clashes leading to destabilization of the catalytic domain flexible loop. We suggest GalNAc-T3 specificity for FGF23 and its ability to control circulating levels of intact FGF23 is achieved by FGF23 being a poor substrate. GalNAc-T3's structure further reveals the molecular bases for reported disease-causing mutations. Our findings provide an insight into how GalNAc-T isoenzymes achieve isoenzyme-specific nonredundant functions.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Maltose solution, BioReagent, ~20% in H2O, Molecular Biology
Sigma-Aldrich
Uridine 5′-diphospho-N-acetylgalactosamine disodium salt, ≥97%